Bibliography

Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,200 peer-reviewed publications.

The CPRD bibliography is updated on a monthly basis (last updated 4 July 2019) and papers are listed below and in the PDF below.

If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.

Download:

(PDF, 3MB, 185 pages)

 

Export 9 results:
Author Title Type [ Year(Asc)]
Filters: Author is Evans, S. J.  [Clear All Filters]
2016
A. A. Root, Wong, A. Y., Ghebremichael-Weldeselassie, Y., Smeeth, L., Bhaskaran, K., Evans, S. J., Brauer, R., Wong, I. C., Navaratnam, V., and Douglas, I., “Evaluation of the risk of cardiovascular events with clarithromycin using both propensity score and self-controlled study designs”, Br J Clin Pharmacol, vol. 82, pp. 512-21, 2016.
N. S. Wexler, Collett, L., Wexler, A. R., Rawlins, M. D., Tabrizi, S. J., Douglas, I., Smeeth, L., and Evans, S. J., “Incidence of adult Huntington's disease in the UK: a UK-based primary care study and a systematic review”, BMJ Open, vol. 6, p. e009070, 2016.
R. Beau-Lejdstrom, Douglas, I., Evans, S. J., and Smeeth, L., “Latest trends in ADHD drug prescribing patterns in children in the UK: prevalence, incidence and persistence”, BMJ Open, vol. 6, p. e010508, 2016.
2015
K. L. Goh, Bhaskaran, K., Minassian, C., Evans, S. J., Smeeth, L., and Douglas, I. J., “Angiotensin receptor blockers and risk of dementia: cohort study in UK Clinical Practice Research Datalink”, Br J Clin Pharmacol, vol. 79, pp. 337-50, 2015.
2013
S. J. Evans, Douglas, I., Rawlins, M. D., Wexler, N. S., Tabrizi, S. J., and Smeeth, L., “Prevalence of adult Huntington's disease in the UK based on diagnoses recorded in general practice records”, J Neurol Neurosurg Psychiatry, vol. 84, pp. 1156-60, 2013.
2012
I. J. Douglas, Evans, S. J., Hingorani, A. D., Grosso, A. M., Timmis, A., Hemingway, H., and Smeeth, L., “Clopidogrel and interaction with proton pump inhibitors: comparison between cohort and within person study designs”, Bmj, vol. 345, p. e4388, 2012.
2010
S. E. McDowell, Coleman, J. J., Evans, S. J., Gill, P. S., and Ferner, R. E., “Laboratory monitoring and adverse patient outcomes with antihypertensive therapy in primary care”, Pharmacoepidemiol Drug Saf, vol. 19, pp. 482-9, 2010.
J. J. Coleman, McDowell, S. E., Evans, S. J., Gill, P. S., and Ferner, R. E., “Oversight: a retrospective study of biochemical monitoring in patients beginning antihypertensive drug treatment in primary care”, Br J Clin Pharmacol, vol. 70, pp. 109-17, 2010.
2009
I. J. Douglas, Evans, S. J., Pocock, S., and Smeeth, L., “The risk of fractures associated with thiazolidinediones: a self-controlled case-series study”, PLoS Med, vol. 6, p. e1000154, 2009.
[Page last reviewed 4 July 2019]